TrialLancet (London, England)2019

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.

William D Tap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.